Control measures in cases of respiratory syncytial vírus infection in premature newborns: A systematic review
DOI:
https://doi.org/10.33448/rsd-v12i11.43755Keywords:
Respiratory syncytial virus infection; Premature; Control measures.Abstract
Objective: To describe the scientific evidence regarding control measures in cases of Respiratory Syncytial Virus (RSV) infection in preterm newborns. Method: This integrative review was conducted in accordance with the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The guiding research question was developed using the Population Interest Context (PICo) strategy: preterm newborns (P - population), control measures (I - phenomenon of interest), in case of Respiratory Syncytial Virus infection (Co - context). Subsequently, the Health Sciences Descriptors (DeCS/BIREME) and Medical Subject Headings (MeSH terms) were consulted, according to Chart 1: Respiratory Syncytial Virus Infection; Prematurity; Control measure. Results: Two studies described recurrent wheezing (RS); another study described two consecutive outbreaks of RSV infection in a Neonatal Intensive Care Unit (NICU), each caused by different RSV genotypes. One article presented current evidence on the etiology, risk factors, diagnosis and management of early and late-onset neonatal sepsis, while another study provided information on the management of community-acquired pneumonia (CAP) in children up to five years of age. Conclusion: The studies found that different control measures can be used in cases of RSV infection in hospitals, such as the use of respiratory precautions, isolation by cohort, monitoring the health status of visitors and staff, prophylactic use of Palivizumab and, above all, frequent and correct hand hygiene by everyone.
References
Alharbi, A. S., Alqwaiee, M., Al-Hindi, M., Mosalli, R., Al-Shamrani, A., Alharbi, S., Yousef, A., Aidaroos, A. A., Turki, A., Alshammary, A., Migdad, A., Said, Y., & Alnemri, A. (2018). Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO). Annals of Thoracic Medicine, 13(3), 127-143.
Bénet, T., Picot, V. S., Awasthi, S., Pandey, N., Bavdekar, A., Kawade, A., Robinson, A., Rakoto-Andrianarivelo, M., Sylla, M., Diallo, S., Russomando, G., Basualdo, W., Komurian-Pradel, F., Endtz, H., Vanhems, P., & Paranhos-Baccalà, G. (2017). Severity of Pneumonia in Under 5-Year-Old Children from Developing Countries: A Multicenter, Prospective, Observational Study. The American Journal of Tropical Medicine and Hygiene, 97(1), 68–76.
Bhuiyan, M. U., Snelling, T. L., West, R., Lang, J., Rahman, T., Granland, C., de Gier, C., Borland, M. L., Thornton, R. B., Kirkham, L.-A. S., Sikazwe, C., Martin, A. C., Richmond, P. C., Smith, D. W., Jaffe, A., & Blyth, C. C. (2019). The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case–control study. Thorax, 74(3), 261–269.
Borchers, A. T., Chang, C., Gershwin, M. E., & Gershwin, L. J. (2013). Respiratory Syncytial Virus—A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 45(3), 331–379.
Brasil. Ministério da saúde. (2022). Secretária de ciência, tecnologia, inovação e insumos estratégicos em saúde. Uso do anticorpo monoclonal Palivizumabe durante a sazonalidade do Virus Sincicial Respiratorio – VSR. Brasília. https://bvsms.saude.gov.br/bvs/publicacoes/anticorpo_palivizumabe_sazonalidade_virus_vsr.pdf
Brasil. Ministério da saúde. (2012). Portaria nº 53, de 30 de novembro de 2012. Decisão de incorporar o medicamento palivizumabe para a prevenção da infecção pelo vírus sincicial respiratório no Sistema Único de Saúde (SUS). https://bvsms.saude.gov.br/bvs/saudelegis/sctie/2012/prt0053_30_11_2012.html
Nascimento‐Carvalho, C. M. (2020). Community‐acquired pneumonia among children: the latest evidence for an updated management. Jornal de Pediatria, 96(1), 29–38.
Jun, S., Sebastianski, M., Featherstone, R., & Robinson, J. (2019). Palivizumab and prevention of childhood respiratory syncytial viral infection: protocol for a systematic review and meta-analysis of breakthrough infections. BMJ Open, 9(7), 1-5.
Li, Y., Wang, X., Blau, D., Caballero, M., Feikin, D., Gill, C., Madhi, S., Omer, S., Simões, E., Campbell, H., Pariente, A., Bardach, D., Bassat, Q., Casalegno, J.-S., Chakhunashvili, G., Crawford, N., Danilenko, D., Anh, L., Do, H., & Echavarria, M. (2022). Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Rev. Lancet, 399, 2047-2064.
Liet, J. M., Ducruet, T., Gupta, V., & Cambonie, G. (2015). Heliox inhalation therapy for bronchiolitis in infants. The Cochrane database of systematic reviews, 2015(9), 1-38.
Lima, M. J. B., Archondo, ME. D. L., & Silva, A. R. da. (2020). Imunoprofilaxia do vírus sincicial respiratório com palivizumabe em crianças em hospital da zona sul de São Paulo. Rev. OFIL-ILAPHAR, 30(1), 33-36.
Bueno Manini, M., Yumi Matsunaga, N., Gianfrancesco, L., Simões Oliveira, M., Vieira de Carvalho, M. R., Leila Martins Tengler Ribeiro, G., de Oliveira Morais, E., Gonçalves O. Ribeiro, M. A., Moreno Morcillo, A., Dirceu Ribeiro, J., & Contrera Toro, A. A. D. (2021). Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab. Jornal Brasileiro de Pneumologia, 47(5), 1-6.
Moher, D., Liberati, A., Tetzlaff, J. & Altman, DG. (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Annals of Internal Medicine, 151(4), 264-270.
Organização Panamericana da Saúde (2023). Reporte Semanal de Influenza, Semana Epidemiológica 8 - OPS/OMS | Organización Panamericana de la Salud. https://www.paho.org/es/documentos/reporte-semanal-influenza-semana-epidemiologica-8-3-marzo-2023
Procianoy, R. S., & Silveira, R. C. (2020). The challenges of neonatal sepsis management. Jornal de Pediatria, 96(1), 80–86.
Rhedin, S., Lindstrand, A., Hjelmgren, A., Ryd-Rinder, M., Öhrmalm, L., Tolfvenstam, T., Örtqvist, Å., Rotzén-Östlund, M., Zweygberg-Wirgart, B., Henriques-Normark, B., Broliden, K., & Naucler, P. (2015). Respiratory viruses associated with community-acquired pneumonia in children: matched case–control study. Thorax, 70(9), 847–853.
Silva, D. G. B. P. da, Almeida, F. J., Arnoni, M. V., Sáfadi, M. A. P., Mimica, M. J., Jarovsky, D., Rossetti, G. P. de A., Magalhães, M., Oliveira, D. B. L. de, Thomazelli, L. M., Colmanetti, T. C., Durigon, E. L., & Berezin, E. N. (2020). First report of two consecutive respiratory syncytial virus outbreaks by the novel genotypes ON-1 and NA-2 in a neonatal intensive care unit. Jornal de Pediatria, 96(2), 233–239.
Simões, M. C. R. dos S., Inoue, Y., Matsunaga, N. Y., Carvalho, M. R. V., Ribeiro, G. L. T., Morais, E. O., Ribeiro, M. A. G. O., Morcillo, A. M., Ribeiro, J. D., & Toro, A. A. D. C. (2019). Recurrent wheezing in preterm infants: Prevalence and risk factors. Jornal de Pediatria, 95(6), 720–727.
Sociedade Brasileira de Pediatria (SBP). (2017). Departamentos Científicos de Cardiologia, Imunizações, Infectologia, Neonatologia e Pneumologia. Diretrizes para o manejo da infecção causada pelo vírus sincicial respiratório (VSR). https://www.sbp.com.br/fileadmin/user_upload/Diretrizes_manejo_infeccao_causada_VSR2017.pdf
Sociedade Brasileira de Pediatria (SBP). (2023). Prevenção ao VSR, muito além de um detalhe. Disponível em: https://www.sbp.com.br/especiais/vsr/
Sociedade de Pediatria do Distrito Federal (SPDF). (2022). Prevenção do Vírus Sincicial Respiratório. https://spdf.com.br/wp-content/uploads/2022/02/Prevencao-do-Virus-Sincicial-Respiratorio_fevereiro_2022_SPDF.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Brenda Caroline da Silva Tibúrcio; Ana Paula Pinho Carvalheira; Ivana Regina Gonçalves
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
